132 related articles for article (PubMed ID: 25415748)
21. MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
Cho MS; Park YY; Yoon J; Yang SY; Baik SH; Lee KY; Kim IY; Kim NK
J Surg Oncol; 2018 Jun; 117(8):1823-1832. PubMed ID: 29790177
[TBL] [Abstract][Full Text] [Related]
22. Routine endoscopic surveillance for local recurrence of rectal cancer is futile.
Martin LA; Gross ME; Mone MC; Whiting CK; Hansen HJ; Mecham EM; Peche W; Scaife CL
Am J Surg; 2015 Dec; 210(6):996-1001; discussion 1001-2. PubMed ID: 26453291
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
24. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.
Brown G; Radcliffe AG; Newcombe RG; Dallimore NS; Bourne MW; Williams GT
Br J Surg; 2003 Mar; 90(3):355-64. PubMed ID: 12594673
[TBL] [Abstract][Full Text] [Related]
25. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer.
Moriya Y; Akasu T; Fujita S; Yamamoto S
Surg Oncol Clin N Am; 2005 Apr; 14(2):225-38. PubMed ID: 15817236
[No Abstract] [Full Text] [Related]
26. The significance of extramural venous invasion in R1 positive rectal cancer.
Ormsby NM; Bermingham HN; Joshi HM; Chadwick M; Samad A; Maitra D; Scott M; Kelly S; Whitmarsh K; Rajaganeshan R
Int J Colorectal Dis; 2017 Jan; 32(1):119-124. PubMed ID: 27695932
[TBL] [Abstract][Full Text] [Related]
27. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.
MERCURY Study Group
Radiology; 2007 Apr; 243(1):132-9. PubMed ID: 17329685
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation.
Chand M; Rasheed S; Heald R; Swift I; West N; Rao S; Tekkis P; Brown G
Colorectal Dis; 2017 Jun; 19(6):537-543. PubMed ID: 27673438
[TBL] [Abstract][Full Text] [Related]
29. The importance of not overstaging mesorectal lymph nodes seen on MRI.
Chand M; Heald RJ; Brown G
Colorectal Dis; 2013; 15(10):1201-4. PubMed ID: 24164749
[No Abstract] [Full Text] [Related]
30. Radiology reporting templates in oncology: a time for change.
Kee D; Zalcberg JR
J Med Imaging Radiat Oncol; 2009 Dec; 53(6):511-3. PubMed ID: 20002280
[No Abstract] [Full Text] [Related]
31. Prostate Imaging--An Update.
Franiel T; Asbach P; Teichgräber U; Hamm B; Foller S
Rofo; 2015 Sep; 187(9):751-9. PubMed ID: 26114251
[TBL] [Abstract][Full Text] [Related]
32. Clinical value of MRI-detected extramural venous invasion in rectal cancer.
Tripathi P; Rao SX; Zeng MS
J Dig Dis; 2017 Jan; 18(1):2-12. PubMed ID: 28009094
[TBL] [Abstract][Full Text] [Related]
33. Degree of error of thin-section MR in measuring extramural depth of tumor invasion in patients with rectal cancer.
Park SH
Radiology; 2008 Feb; 246(2):647; author reply 647-8. PubMed ID: 18227560
[No Abstract] [Full Text] [Related]
34. Correlation Between Magnetic Resonance Imaging-Based Evaluation of Extramural Vascular Invasion and Prognostic Parameters of T3 Stage Rectal Cancer.
Yu J; Huang DY; Xu HX; Li Y; Xu Q
J Comput Assist Tomogr; 2016; 40(4):537-42. PubMed ID: 26966954
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer.
Smith NJ; Barbachano Y; Norman AR; Swift RI; Abulafi AM; Brown G
Br J Surg; 2008 Feb; 95(2):229-36. PubMed ID: 17932879
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological assessment of locally recurrent rectal cancer and relation to local re-recurrence.
Uemura M; Ikeda M; Yamamoto H; Kitani K; Tokuoka M; Matsuda K; Hata Y; Mizushima T; Takemasa I; Sekimoto M; Hosokawa K; Matsuura N; Doki Y; Mori M
Ann Surg Oncol; 2011 Apr; 18(4):1015-22. PubMed ID: 21082358
[TBL] [Abstract][Full Text] [Related]
37. [MR in rectal cancer recurrences].
Gualdi GF; Caterino M; Polettini E; Ceroni L
Radiol Med; 1990 May; 79(5):479-82. PubMed ID: 2359854
[TBL] [Abstract][Full Text] [Related]
38. ACR Appropriateness Criteria Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.
Moy L; Newell MS; Mahoney MC; Bailey L; Barke LD; Carkaci S; D'Orsi C; Goyal S; Haffty BG; Harvey JA; Hayes MK; Jokich PM; Lee SJ; Mainiero MB; Mankoff DA; Patel SB; Yepes MM
J Am Coll Radiol; 2016 Nov; 13(11S):e43-e52. PubMed ID: 27814823
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.
Lim CS; McInnes MDF; Lim RS; Breau RH; Flood TA; Krishna S; Morash C; Shabana WM; Schieda N
J Magn Reson Imaging; 2017 Jul; 46(1):257-266. PubMed ID: 27807914
[TBL] [Abstract][Full Text] [Related]
40. MRI of Rectal Cancer: An Overview and Update on Recent Advances.
Jhaveri KS; Hosseini-Nik H
AJR Am J Roentgenol; 2015 Jul; 205(1):W42-55. PubMed ID: 26102418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
